This study demonstrated the involvement of PREP in the pathogenesis of pulmonary fibrosis and that its inhibition by KYP-2047 has a protective role in lung injury, suggesting PREP as a potential target therapy for pulmonary fibrosis. The gene discussed is PREP; the disease is pulmonary fibrosis.